浅议风药在冠脉血运重建术后胸痛论治中的应用
Application of "Wind Medicine" in the Treatment of Chest Pain after Revascularization
DOI:10.3969/j.issn.1004-745X.2022.04.020
扫 描 看 全 文
1.天津中医药大学第一附属医院,天津 300381
2.天津中医药大学,天津 301617
3.天津中医药大学第二附属医院,天津 300150
扫 描 看 全 文
付焕杰, 刘志超, 王铭扬, 等. 浅议风药在冠脉血运重建术后胸痛论治中的应用[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.1004-745X.2022.04.020
Fu Huanjie, Liu Zhichao, Wang Mingyang, et al. Application of "Wind Medicine" in the Treatment of Chest Pain after Revascularization[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.1004-745X.2022.04.020
付焕杰, 刘志超, 王铭扬, 等. 浅议风药在冠脉血运重建术后胸痛论治中的应用[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.1004-745X.2022.04.020 DOI:
Fu Huanjie, Liu Zhichao, Wang Mingyang, et al. Application of "Wind Medicine" in the Treatment of Chest Pain after Revascularization[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.1004-745X.2022.04.020 DOI:
目前用于治疗冠状动脉粥样硬化性心脏病的手段多样,但仍有部分患者的临床症状不能得到有效改善,基于血运重建术后患者的病理生理变化及脉中积的相关理论,考虑与中医学络脉致病的特点相关,应用“风药”进行治疗后效果良好,故试论“风药”用于治疗冠脉血运重建术后胸痛的作用机理。笔者认为“风药”可发挥一药多效的作用,并与常规的活血化瘀药物功效不同,既可与处方中其他药物相伍发挥协同增效的作用,又可在一定程度上表现出燥湿化痰、化瘀通络等效果。
At present, there are various methods for the treatment of coronary atherosclerotic heart disease, but the clinical symptoms of some patients cannot be effectively improved. Based on the pathophysiological changes of patients after revascularization and the related theory of the accumulation of veins, and considering the characteris⁃tics of the pathogenesis of collaterals in traditional Chinese medicine, the application of"wind medicine"has a good effect after treatment. Thus, in this study, the mechanism of action of the"wind medicine"used to treat chest pain after coronary revascularization was discussed. It is believed that"wind medicine"can play multi-effects as a single drug, which was different from the conventional drugs for promoting blood circulation and removing blood stasis, and could be combined with other drugs in the prescription. The synergistic effect could also show the ef⁃fects of drying dampness and removing phlegm, removing blood stasis and dredging collaterals to a certain extent.
冠心病风药血运重建脉中积疏通经络
Coronary heart diseaseWind medicineRevascularizationStasis in vesselUnblocking collaterals
王传池, 吴珊, 江丽杰, 等.1990~2020年我国冠心病中医证的流行病学调查研究概况[J].中国中医基础医学杂志, 2020, 26(12): 1883-1893.
Stone GW, Ellis SG, Gori T, et al. Blinded outcomes and an⁃gina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORBⅣrandomised trial. Lancet (London, England), 2018, 392 (10157): 1530-1540.
Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease[J]. N Engl J Med, 2020, 382(15): 1395-1407.
索旻, 聂绍平, 艾辉, 等.冠状动脉内旋磨术联合支架置入术后再发胸痛的相关因素分析[J].心肺血管病杂志, 2019, 38(5): 452-456.
方子寒, 张琴, 谢盈彧, 等.阮士怡从“脉中积”理论治疗冠心病冠状动脉粥样硬化经验[J].中医杂志, 2018, 59(21): 1812-1814,1823.
Szwed H, Sadowski Z, Elikowski W, et al. Combination treat⁃ment in stable effort angina using trimetazidine and metopro⁃lol: results of a randomized, double-blind, multicentre study (TRIMPOLⅡ). TRIMetazidine in POLand[J]. Eur Heart, 2001, 22 (24): 2267-2274.
王月娇, 赵波, 马健.李东垣风药运用探析[J].中国中医基础医学杂志, 2015, 21(11): 1352-1353,1360.
王东军, 俞屹婷, 顾超, 等.东垣“风药”钩玄[J].中华中医药杂志, 2016, 31(8): 3106-3108.
李成, 段锦龙, 张津菊, 等.论《脾胃论》升降理论在心系疾病中的应用[J].中华中医药杂志, 2021, 36(7): 3912-3915.
罗再琼.试论风药活血[J].中国中医基础医学杂志, 2001, 7(3): 57-58.
黄淑芬.试论治血先治风[J].中医杂志, 1997, 38(1): 9-11.
王明杰, 黄淑芬.风药增效论[J].新中医, 2006, 38(1): 1-4.
王宇, 李天力, 王显.从“络风内动”理论探讨风药的应用[J].中医杂志, 2019, 60(19): 1647-1650.
吴洋, 赵聪, 王凯, 等.从“络虚风动”学说探讨冠心病[J].中国循证心血管医学杂志, 2021, 13(5): 637-638.
张文宗, 王振涛, 张会超.风药在冠心病中应用的理论探讨[J].中国实验方剂学杂志, 2011, 17(5): 267-269.
刘翀羽.藤类药的应用研究[J].山西中医, 2015, 31(7): 59-60.
刘抒雯, 刘敬霞, 虎喜成, 等.藤类中药治疗缺血性中风作用机制与临床应用[J].新中医, 2015, 47(5): 4-6.
秦楚峰, 夏梦幻, 杨丹倩, 等.试从“七郁”病机论冠心病的发病机制[J].中医杂志, 2021, 62(18): 1594-1597.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构